- Oops!Something went wrong.Please try again later.
MarketWatch's Fast Foodist tries Wendy's 'hot and crispy' fries, which are engineered to not get soggy.
Shares of BeyondSpring Inc. plunged 55.2% toward a record low in premarket trading Wednesday, after the biopharmaceutical company said that it has received a complete response letter (CRL) from the U.S. Food and Drug Administration, saying the biopharmaceutical company's new drug application (NDA) for its treatment for chemotherapy-induced neutropenia (CIN) "cannot be approved in its present form." The FDA said the results of the single registration trial (106 Phase 3) "was not sufficiently robu
Many companies use the term "artificial intelligence" (AI) to generate hype, but few of them successfully integrate AI to grow their business. Both Upstart Holdings (NASDAQ: UPST) and UiPath (NYSE: PATH) have used AI to drive their businesses. Upstart is using artificial intelligence to redefine how banks determine creditworthiness for loans.
Omicron, which was first sequenced in South Africa, is believed to be extremely contagious, though not necessarily especially severe. The US banned travel from eight southern African countries, of which two, South Africa and Botswana, have reported cases. In a 2009 essay he co-authored, titled What is a Pandemic?, Anthony Fauci, the White House chief medical advisor who leads the US covid-19 response, discussed the complicated matter of defining a pandemic as opposed, for instance, to endemic disease.
The stock market may be uncertain, but there are still plenty of opportunities for savvy investors. If you're looking for new ideas, keep reading to see why our writers recommend Teladoc (NYSE: TDOC), Duolingo (NASDAQ: DUOL), AT&T (NYSE: T), MercadoLibre (NASDAQ: MELI) and Zoom Video Communications (Nasdaq: ZM) as top stocks to buy in December. Keith Speights (Teladoc Health): There's a good chance that the omicron variant will be the most important factor affecting the stock market in December.
For you unbridled growth investors, the stock that could make you a lot richer this month and well beyond is Singapore-based Sea Limited (NYSE: SE). Sea has had a monumental run-up since the bear-market bottom 20 months ago.
The Yahoo Finance Live panel discusses the earnings reports from Salesforce, Allbirds, and HP Enterprise.
The S&P 500 is up 25% so far this year. That's after a 16% 2020 gain despite the COVID-19 pandemic. Gains this high are not normal, as the market tends to average around 8% a year over the long term.
Prior to it becoming a popular meme stock earlier this year, Sundial Growers (NASDAQ: SNDL) was nothing more than a struggling cannabis business that may have found it difficult to stand apart from other pot stocks. With an influx of cash plus multiple acquisitions this year, Sundial Growers is a much different business and is now a top cannabis retailer in Canada. Should investors expect another acquisition in 2022?
Shares of Teladoc Health (NYSE: TDOC) have been absolutely pummeled this year. Let's take a look at the underlying business and consider the company's long-term prospects to see if this may be a good time to buy this growth stock. Anyone taking a look at Teladoc stock should first take a moment to pick apart the company's organic growth from its reported growth.
Reddit investors get dumped on because they cling to notions that monied interests are holding back their favorite meme stocks and endlessly cheer the next big short squeeze. There are actually some very smart investors on Reddit and quite a number of the stocks they discuss are very good, well-financed businesses that don't need their shares jawboned above penny stock valuations. Here are two of the most popular Reddit stocks that an investor can actually buy and hold for years to come.
Shares of uranium mining companies Denison Mines (NYSEMKT: DNN), Energy Fuels (NYSEMKT: UUUU), and Uranium Energy (NYSEMKT: UEC) all crashed in Tuesday trading, falling 7%, 8.6%, and a disheartening 11.9%, respectively, through 1:25 p.m. ET. Since hitting its recent high of roughly $48 a pound on Nov. 15, uranium prices have twice more tried to break that barrier and resume their march toward $60 -- and twice failed, according to data from TradingEconomics.com. Today, uranium prices sit at just $47.25 a pound, which, granted, is about 50% higher than their lows of mid-August, but also still a far way away from $60.
There's little question that streaming video has been the driving force behind Walt Disney's (NYSE: DIS) stock price changes over the past couple of years. At its investor day event in early 2019, the company revealed plans to introduce its Disney+ service, which began an epic run that saw its stock price gain as much as 68% in the two years that followed. Disney isn't planning to stand idly by; it recently revealed plans to reinvigorate growth of the company's diamond-in-the-rough.
The topsy-turvy market action we've seen over the past week continued on Wednesday morning, with many market participants breathing a sigh of relief as stocks looked poised to climb and regain some of their losses from Tuesday. S&P 500 (SNPINDEX: ^GSPC) futures gained 56 points to 4,622, and Nasdaq Composite (NASDAQINDEX: ^IXIC) futures were up 219 points to 16,369. It's the first day of the month, and that means Chinese electric vehicle companies are reporting their latest delivery figures.
The video gaming hardware company is about to outgrow its video gaming roots.
Scientists out of South Africa reported the discovery of a new strain of the coronavirus among positive cases in the region.
Shares of ImmunoGen (NASDAQ: IMGN) surged 30% on Tuesday after the biotech announced promising clinical trial results for its experimental ovarian cancer therapy, mirvetuximab. The trial was designed to assess the safety and efficacy of mirvetuximab in patients with a form of platinum-resistant ovarian cancer who were already treated with Avastin (bevacizumab), a leading therapy developed by Roche-owned Genentech. "Despite advances in the platinum-sensitive setting, most patients with ovarian cancer eventually develop platinum-resistant disease, for which there are limited treatment options, especially for those patients who have previously received bevacizumab," co-principal investigator Robert Coleman said in a press release.
Salesforce stock tumbled after the software maker reported third-quarter results that topped estimates but guidance disappointed.
Moderna (NASDAQ: MRNA) has been one of the hottest buys on the stock market over the past few years due to its COVID-19 vaccine. Retail investors are big fans of Moderna, and even if it generates underwhelming results next year, it could still produce great returns -- largely because it could be the next big meme stock.
Pfizer (NYSE: PFE) has been the second-best-performing big pharma stock for the whole of 2021. Pfizer's shares have soared this year due to its dominance in the COVID-19 vaccine market, as well as its late-stage trial success with the oral antiviral pill Paxlovid. Despite this sizable jump in 2021, Pfizer seems primed to crush the broader market yet again in 2022.
Shares of Vir Biotechnology (NASDAQ: VIR) were soaring 18.5% as of 11:08 a.m. ET on Tuesday. The big gain came after H.C. Wainwright analyst Patrick Trucchio boosted his price target on Vir from $135 to $200. Several analysts are bullish about Vir's prospects.